Chronic Lymphocytic Leukemia
Therapeutic response
Precision oncology relationships for therapeutic response involving this cancer type.
| Type | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| Sensitivity (+) | CD20 + | Chronic Lymphocytic Leukemia | Cyclophosphamide, Fludarabine, Rituximab | |
| Sensitivity (+) | 17p deletion | Chronic Lymphocytic Leukemia | Ibrutinib |